
Quidel A112/A113 Normal Human
Serum Complement 正常人血清补体- 询价
- Quidel
- A112/A113
- 美国
- 2025年09月09日
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 库存:
现货
- 英文名:
Normal Human Serum Complement
- CAS号:
无
- 保质期:
1年
- 供应商:
冠峰生物 18916708231
- 保存条件:
-70度
Quidel公司(QuidelCorporation)成立于1979年,总部位于美国,从事传染病点保健和生殖与妇女健康的诊断解决方案的开发,制造及销售。公司现拥有员工共322人。是一家在美国纳斯达克上市的综合性临床诊断产品生产商和健康服务研发型企业,*票代码(Nasdaq:QDEL),其部分快速诊断产品占据美国主流市场。
| 品牌 |
货号
|
英文名
|
中文名
|
规格
|
货期
|
|
Quidel
|
A112
|
Quidel Normal Human Serum Complement
|
正常人血清补体
|
2.5ml
|
现货
|
|
Quidel
|
A113
|
Quidel Normal Human Serum Complement
|
正常人血清补体
|
5ml
|
现货 |
参考资料:
1、Idusogie, E.E.,Presta, L.,et al.Mapping of the C1q binding site on Rituxan, a chimeric antibody with a human IgG1 FC. J. Immunol 164:4178- 4184 (2000).
2、Hinton, PR.,Xiong,J., et al An Engineered Human IgG1 Antibody with Longer Serum Half-Life. J Immunol 176:346-356 (2006).
3、Dall’Acqua, W.F., Cook, K.E., et al. Modulation of the Effector Functions of a Human IgG1 through Engineering of Its Hinge Region. J Immunol 177:1129-1138 (2006).
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验The OP9-DL1 System: Generation of T-Lymphocytes from Embryonic or Hematopoietic Stem Cells In Vitro
. 36. Resuspend the cells in OP9 medium, seed 5 x 105 cells per 10-cm dish containing ~80% confluent OP9 cells in 10 mL of OP9 medium, and add 5 ng/mL of recombinant human Flt-3L. Return the dish to the incubator. The number of 10-cm dishes
response may follow the transfusion of serum proteins between humans, but a vigorous immune response (serum sickness) commonly follows transfusion of horse serum proteins to a human the host's genetic makeup, especially the MHC
response may follow the transfusion of serum proteins between humans, but a vigorous immune response (serum sickness) commonly follows transfusion of horse serum proteins to a human the host's genetic makeup, especially the MHC
技术资料暂无技术资料 索取技术资料







